TORONTO, March 3, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of ...

"Receiving orphan drug designation from the FDA is a significant milestone for DiagnaMed and validates the promise of molecular hydrogen as a potential treatment for ALS. We are excited to partner ...

No in between." Molecular hydrogen therapy, which Olivia is exploring, involves inhaling hydrogen gas or drinking hydrogen-rich water. Numerous cosmetic clinics, including Olivia's go-to in ...